p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2
- PMID: 22123926
- DOI: 10.1158/0008-5472.CAN-11-1215
p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2
Abstract
In cancer cells, the aberrant conversion of pyruvate into lactate instead of acetyl-CoA in the presence of oxygen is known as the Warburg effect. The consequences and mechanisms of this metabolic peculiarity are incompletely understood. Here we report that p53 status is a key determinant of the Warburg effect. Wild-type p53 expression decreased levels of pyruvate dehydrogenase kinase-2 (Pdk2) and the product of its activity, the inactive form of the pyruvate dehydrogenase complex (P-Pdc), both of which are key regulators of pyruvate metabolism. Decreased levels of Pdk2 and P-Pdc in turn promoted conversion of pyruvate into acetyl-CoA instead of lactate. Thus, wild-type p53 limited lactate production in cancer cells unless Pdk2 could be elevated. Together, our results established that wild-type p53 prevents manifestation of the Warburg effect by controlling Pdk2. These findings elucidate a new mechanism by which p53 suppresses tumorigenesis acting at the level of cancer cell metabolism.
Similar articles
-
Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding.Arch Biochem Biophys. 2001 Nov 15;395(2):246-52. doi: 10.1006/abbi.2001.2586. Arch Biochem Biophys. 2001. PMID: 11697863
-
Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.Cancer Res. 2009 Jul 15;69(14):5978-86. doi: 10.1158/0008-5472.CAN-09-0244. Epub 2009 Jun 30. Cancer Res. 2009. PMID: 19567674
-
Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.Biochem J. 2003 Feb 1;369(Pt 3):687-95. doi: 10.1042/BJ20021509. Biochem J. 2003. PMID: 12435272 Free PMC article.
-
Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.Int J Biochem Cell Biol. 2011 Jul;43(7):969-80. doi: 10.1016/j.biocel.2010.02.005. Epub 2010 Feb 13. Int J Biochem Cell Biol. 2011. PMID: 20156581 Review.
-
Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.Curr Drug Targets Immune Endocr Metabol Disord. 2002 Jul;2(2):151-65. Curr Drug Targets Immune Endocr Metabol Disord. 2002. PMID: 12476789 Review.
Cited by
-
Pan-cancer analysis reveals PDK family as potential indicators related to prognosis and immune infiltration.Sci Rep. 2024 Mar 7;14(1):5665. doi: 10.1038/s41598-024-55455-1. Sci Rep. 2024. PMID: 38453992 Free PMC article.
-
Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer.Oncotarget. 2017 Jul 15;8(41):69779-69796. doi: 10.18632/oncotarget.19266. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050241 Free PMC article.
-
KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis.Cell Rep. 2016 Sep 13;16(11):3016-3027. doi: 10.1016/j.celrep.2016.08.018. Cell Rep. 2016. PMID: 27626669 Free PMC article.
-
Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways.Front Cell Dev Biol. 2024 Jun 12;12:1399065. doi: 10.3389/fcell.2024.1399065. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38933330 Free PMC article. Review.
-
Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma.Front Mol Biosci. 2022 Aug 16;9:947208. doi: 10.3389/fmolb.2022.947208. eCollection 2022. Front Mol Biosci. 2022. PMID: 36052168 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous